Fingerprint
Dive into the research topics of 'Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Kerri Beckmann*, Hans Garmo, Bertil Lindahl, Lars Holmberg, Pär Stattin, Jan Adolfsson, J. Kennedy Cruickshank, Mieke Van Hemelrijck
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
15
Citations
(Scopus)